Extent of Lymphadenectomy for Surgical Management of Right-Sided Colon Cancer: The Randomized Phase III RELARC Trial

Junyang Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ang Li(Baylor College of Medicine), Yuelun Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Huang(Fujian Medical University), Ze Fu, Dongjian Ji(Peking University), Bin Wu(Shenzhen Second People's Hospital), Xiangqian Su(Peking University), Chenghai Zhang(Peking University Cancer Hospital), Changzheng He(Ruijin Hospital), Aiwen Wu(Peking University), Guannan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yueming Sun(Nanjing Medical University), Weizhong Jiang(Peking University People's Hospital), Ziqiang Wang(Sichuan University), Lu Zang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingjiang Ye(Peking University), Lai Xu(Qingdao University), Qingbin Wu(Peking University), Peng‐Ju Chen, Xiaohui Du(Shandong Tumor Hospital), Wen‐Long Guan(Sun Yat-sen University), Minhua Zheng(Ruijin Hospital), Xiangbing Deng(Sichuan University), Liang Kang(Sun Yat-sen University), Jianmin Xu(Zhongshan Hospital), Yifei Feng(Nanjing Medical University), Zhongtao Zhang(Capital Medical University), Pan Chi(Fujian Medical University), Fei Li(Xiamen Medical College), Yunfeng Yao, Yang Luo, Anlong Zhu(Harbin Medical University), Ming Zhong(Sun Yat-sen University), Jiadi Xing(Peking University Cancer Hospital), Tao Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian Suo(Jilin University), Yi Xiao(Chinese Academy of Agricultural Sciences), Haijun Deng(Nanfang Hospital), Lei Chen(Peking University Cancer Hospital), Bo Feng(Zhejiang University), Kefeng Ding(Zhejiang University), Zirui He(Ruijin Hospital), Huizhong Qiu, Minhao Yu(Jiangsu Province Hospital), Guole Lin, Shidong Hu(Chinese PLA General Hospital)
Journal of Clinical Oncology
August 27, 2024
Cited by 43


Related Papers